全文获取类型
收费全文 | 4675篇 |
免费 | 350篇 |
国内免费 | 14篇 |
专业分类
耳鼻咽喉 | 45篇 |
儿科学 | 84篇 |
妇产科学 | 187篇 |
基础医学 | 686篇 |
口腔科学 | 27篇 |
临床医学 | 460篇 |
内科学 | 876篇 |
皮肤病学 | 35篇 |
神经病学 | 511篇 |
特种医学 | 161篇 |
外科学 | 629篇 |
综合类 | 126篇 |
一般理论 | 3篇 |
预防医学 | 377篇 |
眼科学 | 94篇 |
药学 | 363篇 |
中国医学 | 8篇 |
肿瘤学 | 367篇 |
出版年
2023年 | 19篇 |
2022年 | 32篇 |
2021年 | 64篇 |
2020年 | 49篇 |
2019年 | 74篇 |
2018年 | 98篇 |
2017年 | 71篇 |
2016年 | 94篇 |
2015年 | 111篇 |
2014年 | 134篇 |
2013年 | 199篇 |
2012年 | 318篇 |
2011年 | 350篇 |
2010年 | 179篇 |
2009年 | 157篇 |
2008年 | 290篇 |
2007年 | 332篇 |
2006年 | 332篇 |
2005年 | 318篇 |
2004年 | 339篇 |
2003年 | 259篇 |
2002年 | 250篇 |
2001年 | 49篇 |
2000年 | 64篇 |
1999年 | 74篇 |
1998年 | 65篇 |
1997年 | 52篇 |
1996年 | 40篇 |
1995年 | 32篇 |
1994年 | 38篇 |
1993年 | 44篇 |
1992年 | 38篇 |
1991年 | 32篇 |
1990年 | 31篇 |
1989年 | 30篇 |
1988年 | 28篇 |
1987年 | 19篇 |
1986年 | 27篇 |
1985年 | 28篇 |
1984年 | 23篇 |
1983年 | 24篇 |
1982年 | 17篇 |
1981年 | 16篇 |
1980年 | 14篇 |
1979年 | 16篇 |
1978年 | 14篇 |
1977年 | 21篇 |
1974年 | 13篇 |
1973年 | 13篇 |
1971年 | 12篇 |
排序方式: 共有5039条查询结果,搜索用时 0 毫秒
91.
Travis M Falconer John W Eikelboom Graeme J Hankey Paul E Norman 《Clinical Interventions in Aging》2008,3(1):17-23
Symptomatic and asymptomatic peripheral arterial disease (PAD) is a common problem in the elderly. The management of PAD includes the prevention of cardiovascular events and relief of symptoms – most commonly intermittent claudication (IC). Both require treatment of the causes and consequences of atherothrombosis, but some strategies are more effective for prevention of cardiovascular events and others are more effective for the relief of symptoms. Priorities for the prevention of cardiovascular events include smoking cessation, exercise, antiplatelet therapy, and the treatment of dyslipidemia, hypertension, and diabetes. Walking time and ability are improved by exercise. The benefit of numerous drugs in the treatment of IC has been assessed. The results have generally been disappointing, but there is some evidence that statins and cilostazol (an inhibitor of phosphodiesterase 3) are of benefit. Meta-analyses suggest that cilostazol increases maximum walking distance by 40%–50% and improves other objective measures of walking. The safety profile of cilostazol in patients with PAD appears to be acceptable although the mechanism for its effect on IC is unclear. In addition to risk factor management, treatment with cilostazol should be considered in patients with disabling IC. 相似文献
92.
93.
Cara Nethercott Amanda N. Mabbett Makrina Totsika Paul Peters Juan C. Ortiz Graeme R. Nimmo Geoffrey W. Coombs Mark J. Walker Mark A. Schembri 《Journal of clinical microbiology》2013,51(7):2131-2138
Infective endocarditis (IE) is a life-threatening infection of the heart endothelium and valves. Staphylococcus aureus is a predominant cause of severe IE and is frequently associated with infections in health care settings and device-related infections. Multilocus sequence typing (MLST), spa typing, and virulence gene microarrays are frequently used to classify S. aureus clinical isolates. This study examined the utility of these typing tools to investigate S. aureus epidemiology associated with IE. Ninety-seven S. aureus isolates were collected from patients diagnosed with (i) IE, (ii) bloodstream infection related to medical devices, (iii) bloodstream infection not related to medical devices, and (iv) skin or soft-tissue infections. The MLST clonal complex (CC) for each isolate was determined and compared to the CCs of members of the S. aureus population by eBURST analysis. The spa type of all isolates was also determined. A null model was used to determine correlations of IE with CC and spa type. DNA microarray analysis was performed, and a permutational analysis of multivariate variance (PERMANOVA) and principal coordinates analysis were conducted to identify genotypic differences between IE and non-IE strains. CC12, CC20, and spa type t160 were significantly associated with IE S. aureus. A subset of virulence-associated genes and alleles, including genes encoding staphylococcal superantigen-like proteins, fibrinogen-binding protein, and a leukocidin subunit, also significantly correlated with IE isolates. MLST, spa typing, and microarray analysis are promising tools for monitoring S. aureus epidemiology associated with IE. Further research to determine a role for the S. aureus IE-associated virulence genes identified in this study is warranted. 相似文献
94.
Thomas Klopstock MD Aleksandar Videnovic MD Almut Turid Bischoff MD Cecilia Bonnet MD Laura Cif MD Cynthia Comella MD Marta Correa-Vela MD Maria L. Escolar MD Jamie L. Fraser MD Victoria Gonzalez MD Neal Hermanowicz MD Robert Jech MD Hyder A. Jinnah MD Tomasz Kmiec MD Anthony Lang MD Maria J. Martí MD Saadet Mercimek-Andrews MD Migvis Monduy MD Graeme A.M. Nimmo MBBS Belen Perez-Dueñas MD Helle Cecilie Viekilde Pfeiffer MD Lluis Planellas MD Emmanuel Roze MD Nivedita Thakur MD Laura Tochen MD Nora Vanegas-Arroyave MD Giovanna Zorzi MD Colleen Burns PhD Feriandas Greblikas MD 《Movement disorders》2021,36(6):1342-1352
95.
Edwards Richard Greenwood Hannah E. McRobbie Graeme Khan Imtiaz Witney Timothy H. 《Molecular imaging and biology》2021,23(6):854-864
Molecular Imaging and Biology - (S)-4-(3-18F-Fluoropropyl)-?-Glutamic Acid ([18F]FSPG) is a radiolabeled non-natural amino acid that is used for positron emission tomography (PET) imaging of... 相似文献
96.
97.
Does fetal growth restriction lead to increased brain injury as detected by neonatal cranial ultrasound in premature infants?
下载免费PDF全文
![点击此处可从《Journal of paediatrics and child health》网站下载免费的PDF全文](/ch/ext_images/free.gif)
98.
Tihana Bicanic Christian Bottomley Angela Loyse Annemarie E. Brouwer Conrad Muzoora Kabanda Taseera Arthur Jackson Jacob Phulusa Mina C. Hosseinipour Charles van der Horst Direk Limmathurotsakul Nicholas J. White Douglas Wilson Robin Wood Graeme Meintjes Thomas S. Harrison Joseph N. Jarvis 《Antimicrobial agents and chemotherapy》2015,59(12):7224-7231
Amphotericin B deoxycholate (AmBd) is the recommended induction treatment for HIV-associated cryptococcal meningitis (CM). Its use is hampered by toxicities that include electrolyte abnormalities, nephrotoxicity, and anemia. Protocols to minimize toxicity are applied inconsistently. In a clinical trial cohort of AmBd-based CM induction treatment, a standardized protocol of preemptive hydration and electrolyte supplementation was applied. Changes in blood counts, electrolyte levels, and creatinine levels over 14 days were analyzed in relation to the AmBd dose, treatment duration (short course of 5 to 7 days or standard course of 14 days), addition of flucytosine (5FC), and outcome. In the 368 patients studied, the hemoglobin levels dropped by a mean of 1.5 g/dl (95% confidence interval [CI], 1.0 to 1.9 g/dl) following 7 days of AmBd and by a mean of 2.3 g/dl (95% CI, 1.1 to 3.6 g/dl) after 14 days. Serum creatinine levels increased by 37 μmol/liter (95% CI, 30 to 45 μmol/liter) by day 7 and by 49 μmol/liter (95% CI, 35 to 64μmol/liter) by day 14 of AmBd treatment. Overall, 33% of patients developed grade III/IV anemia, 5.6% developed grade III hypokalemia, 9.5% had creatinine levels that exceeded 220 μmol, and 6% discontinued AmBd prematurely. The addition of 5FC was associated with a slight increase in anemia but not neutropenia. Laboratory abnormalities stabilized or reversed during the second week in patients on short-course induction. Grade III/IV anemia (adjusted odds ratio [aOR], 2.2; 95% CI, 1.1 to 4.3; P = 0.028) and nephrotoxicity (aOR, 4.5; 95% CI, 1.8 to 11; P = 0.001) were risk factors for 10-week mortality. In summary, routine intravenous saline hydration and preemptive electrolyte replacement during AmBd-based induction regimens for HIV-associated CM minimized the incidence of hypokalemia and nephrotoxicity. Anemia remained a concerning adverse effect. The addition of flucytosine was not associated with increased neutropenia. Shorter AmBd courses were less toxic, with rapid reversibility. 相似文献
99.
Jayme E. Locke Shikha Mehta Rhiannon D. Reed Paul MacLennan Allan Massie Anoma Nellore Christine Durand Dorry L. Segev 《Journal of the American Society of Nephrology : JASN》2015,26(9):2222-2229
Kidney transplantation is a viable treatment for select patients with HIV and ESRD, but data are lacking regarding long-term outcomes and comparisons with appropriately matched HIV-negative patients. We analyzed data from the Scientific Registry of Transplant Recipients (SRTR; 2002–2011): 510 adult kidney transplant recipients with HIV (median follow-up, 3.8 years) matched 1:10 to HIV-negative controls. Compared with HIV-negative controls, HIV-infected recipients had significantly lower 5-year (75.3% versus 69.2%) and 10-year (54.4% versus 49.8%) post-transplant graft survival (GS) (hazard ratio [HR], 1.37; 95% confidence interval [95% CI], 1.15 to 1.64; P<0.001) that persisted when censoring for death (HR, 1.43; 95% CI, 1.12 to 1.84; P=0.005). However, compared with HIV-negative/hepatitis C virus (HCV)–negative controls, HIV monoinfected recipients had similar 5-year and 10-year GS, whereas HIV/HCV coinfected recipients had worse GS (5-year: 64.0% versus 52.0%, P=0.02; 10-year: 36.2% versus 27.0%, P=0.004 [HR, 1.38; 95% CI, 1.08 to 1.77; P=0.01]). Patient survival (PS) among HIV-infected recipients was 83.5% at 5 years and 51.6% at 10 years and was significantly lower than PS among HIV-negative controls (HR, 1.34; 95% CI, 1.08 to 1.68; P<0.01). However, PS was similar for HIV monoinfected recipients and HIV-negative/HCV-negative controls at both times. HIV/HCV coinfected recipients had worse PS compared with HIV-negative/HCV-infected controls (5-year: 67.0% versus 78.6%, P=0.007; 10-year: 29.3% versus 56.23%, P=0.002 [HR, 1.57; 95% CI, 1.11 to 2.22; P=0.01]). In conclusion, HIV-negative and HIV monoinfected kidney transplant recipients had similar GS and PS, whereas HIV/HCV coinfected recipients had worse outcomes. Although encouraging, these results suggest caution in transplanting coinfected patients. 相似文献
100.